Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
03/19/1997 | EP0762881A1 Method and reagents for the treatment of rheumatoid arthritis |
03/19/1997 | EP0659191A4 Cloning and expression of pur protein. |
03/19/1997 | EP0626861B1 Treatment for asthma |
03/19/1997 | EP0445135B1 Immogenically active fractions of borrelia burgdorferi |
03/19/1997 | CN1145641A DNA mutagenesis by random fragmentation and reassembly |
03/19/1997 | CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
03/19/1997 | CN1145369A Peptide useful as ligand |
03/19/1997 | CA2182541A1 Novel, ubiquitous potassium-channel proteins and genes for the same |
03/19/1997 | CA2181880A1 Atp-sensitive potassium-channel proteins and their genes |
03/18/1997 | US5612895 Method of rational drug design based on ab initio computer simulation of conformational features of peptides |
03/18/1997 | US5612486 Transgenic animals harboring APP allele having swedish mutation |
03/18/1997 | US5612459 Production and characteristics of anti-teicoplanin polyclonal antibody |
03/18/1997 | US5612458 Antibody to PNA/nucleic acid complexes |
03/18/1997 | US5612332 Inhibiting protein glycosylation |
03/18/1997 | US5612216 Nucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereof |
03/18/1997 | US5612205 Producing dna segments |
03/18/1997 | US5612201 Genetic engineering and kits for determination of gene expression |
03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine |
03/18/1997 | US5612182 Mycobacteriophage specific for the mycobacterium tuberculosis complex |
03/18/1997 | US5612042 Vaccine against streptococcus suis infection |
03/18/1997 | US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers |
03/18/1997 | US5612034 Super-globuling for in vivo extended lifetimes |
03/18/1997 | US5612033 Methods of treatment using heat-treated IGM antibody preparations |
03/18/1997 | US5612032 Method for diagnosing tumors using mouse monoclonal antibodies |
03/18/1997 | US5612031 Dentistry |
03/18/1997 | US5612030 Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
03/18/1997 | US5612016 Conjugates of antibodies and bifunctional ligands |
03/18/1997 | CA2031528C Radionuclide metal chelates for the radiolabeling of proteins |
03/13/1997 | WO1997009436A1 Method for producing phage display vectors |
03/13/1997 | WO1997009433A1 Cell-cycle checkpoint genes |
03/13/1997 | WO1997009432A1 Cyclin-dependent kinase |
03/13/1997 | WO1997009429A2 Compounds and methods for diagnosis of tuberculosis |
03/13/1997 | WO1997009427A1 Vegf-related protein |
03/13/1997 | WO1997009425A1 Cerebellum-derived growth factors, and uses related thereto |
03/13/1997 | WO1997009418A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
03/13/1997 | WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy |
03/13/1997 | WO1997009349A1 Binding protein |
03/13/1997 | WO1997009345A1 Virus protein purification from virosomes |
03/13/1997 | WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
03/13/1997 | WO1997009341A1 Cyclin e variants and use thereof |
03/13/1997 | WO1997009065A1 Remedy for autoimmune disease |
03/13/1997 | WO1997009063A1 Uses of tfpi inhibitor for treatment of cancer |
03/13/1997 | WO1997009055A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
03/13/1997 | WO1997005256A3 Mammalian pro-hormone convertase |
03/13/1997 | WO1997005170A3 Broad specificity antibodies |
03/13/1997 | WO1996040041A3 Antibodies to fas antigen capable of inhibiting apoptosis |
03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide |
03/13/1997 | WO1996033279A3 Repertoire cloning process, products derived therefrom and uses for said products |
03/13/1997 | CA2231400A1 Vegf-related protein |
03/13/1997 | CA2231190A1 Cell-cycle checkpoint genes |
03/13/1997 | CA2231182A1 Recombinant anti-cd4 antibodies for human therapy |
03/13/1997 | CA2231045A1 Method for producing phage display vectors |
03/13/1997 | CA2230927A1 Compounds and methods for diagnosis of tuberculosis |
03/13/1997 | CA2230858A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor |
03/13/1997 | CA2230795A1 Cyclin e variants and use thereof |
03/13/1997 | CA2228667A1 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
03/13/1997 | CA2228604A1 Isolation of microdomains of caveolae and gpi-anchored proteins |
03/13/1997 | CA2227301A1 Hcv binding protein |
03/12/1997 | EP0761819A1 Exopolysaccharides of burkholderia pseudomallei and burkholderia mallei |
03/12/1997 | EP0761814A1 Antibody 103 B2 to a peanut agglutinin(PNA)-binding glycoprotein on cell surfaces |
03/12/1997 | EP0761688A2 Production, and therapeutic combinations, of antibodies |
03/12/1997 | EP0761687A1 Process for preparing antibody |
03/12/1997 | EP0761685A2 Macrophage-derived inflammatory mediator (mip-1 alpha and mip-1 beta) |
03/12/1997 | EP0761233A2 Transkaryotic implantation |
03/12/1997 | EP0761232A1 Antiallergic agent comprising anti-PAF receptor antibodies |
03/12/1997 | EP0761034A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
03/12/1997 | EP0760864A1 Dna encoding glutamate gated chloride channels |
03/12/1997 | EP0760857A1 Receptor for oncostatin m |
03/12/1997 | EP0760852A1 Immunosuppressant target proteins |
03/12/1997 | EP0760851A1 Tumor necrosis factor receptor-associated factors |
03/12/1997 | EP0760850A1 P2x RECEPTORS (PURINOCEPTOR FAMILY) |
03/12/1997 | EP0760823A1 CLONED $i(LEPTOSPIRA) OUTER MEMBRANE PROTEIN |
03/12/1997 | EP0760685A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
03/12/1997 | EP0760601A1 Predicting fetal membrane rupture by mmp-9 activity |
03/12/1997 | EP0538283B1 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
03/12/1997 | EP0489048B1 Inhibition of tumor growth by blockade of the protein c system |
03/12/1997 | CN1145077A Immuno-stimulatory monoclonal antibodies |
03/12/1997 | CN1145076A Prostaglandin I2 receptor |
03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
03/11/1997 | US5610288 Antisense polynucleotide inhibition of epidermal human growth factor receptor expression |
03/11/1997 | US5610283 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels |
03/11/1997 | US5610282 cDNA encoding a rat D1 dopamine receptor linked to adenylyl cyclase activation and expression of the receptor protein in plasmid-transfected cell lines |
03/11/1997 | US5610281 Monoclonal antibody which specifically binds to human e-cadherin |
03/11/1997 | US5610280 Antitumor |
03/11/1997 | US5610279 Human TNF receptor |
03/11/1997 | US5610276 Determination whether a cell is cancerous |
03/11/1997 | US5610058 Cytotrophoblast antigen and monoclonal antibodies which specifically bind cytotrophoblast cells |
03/11/1997 | US5610057 Monoclonal antibody specific for IgA receptor |
03/11/1997 | US5610035 Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies |
03/11/1997 | US5610034 Immunoglobulin production by trichoderma |
03/11/1997 | US5610024 Contacting sample with activated protein c and reactants for determining antihemophilic factor activity; incubation, evaluation |
03/11/1997 | US5610023 Method of purification of clostridium difficile toxin A and production of mono-specific antibodies |
03/11/1997 | US5610021 Compositions and methods for identification and use of soluble complex forms of osteogenic proteins |
03/11/1997 | US5610018 Mitogenic signal transduction pathway |
03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
03/11/1997 | US5610009 Mammalian expression systems for hepatitis C virus envelope genes |
03/11/1997 | US5609872 Peptides comprising a protective epitope from blood stages of plasmodium falciparum |
03/11/1997 | US5609870 Antisecretory, immunology |
03/11/1997 | US5609869 For use in diagnosis and therapy |